New TGCT Educational Program Explores Emerging Systemic Treatment Options October 14, 2026 PeerView Institute for Medical Education has launched an educational activity focused on emerging clinical evidence and systemic treatment options for patients with tenosynovial giant cell tumor (TGCT) whose disease is not amenable to surgery or is recurrent or progressive. Developed in collaboration with the Sarcoma Alliance for Research through Collaboration (SARC), the program features a panel of experts and a patient advocate discussing evolving treatment strategies and patient-centered care. Healthcare professionals can watch the program for practical guidance on identifying patients who may benefit from colony-stimulating factor 1 receptor (CSF1R) inhibitors and understanding how these therapies may influence treatment decisions and improve patient outcomes. Click here to watch the program Categories: Education, Sarcoma News